Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2375
Title: Cannabidoil Oil eValuation for Endometriosis symptom Regression - a pilot study protocol (COVER pilot study).
Epworth Authors: Francis, Alaina
Tyson, Kate
Nation, Tamara
Mooney, Samantha
Mckenzie, Dean
Amir, Michal
Frawley, Helena
Maccan, Helen
da Gama, Rafaella Pires Rebelo
Holdsworth-Carson, Sarah
Keywords: Cannabidiol Oil
Cannabidiol
CBD
Endometriosis
Chronic Pelvic Pain
Neuropathic Pain
Nociceptive Pain
CPP
Julia Argyrou Endometriosis Centre, Epworth HealthCare, Victoria, Australia
Women’s and Children’s Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Aug-2025
Conference Name: Epworth HealthCare Research Week 2025
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: In recent years, there has been a growing interest and exploration of Cannabidoil (CBD) as a potential therapeutic agent for the management for chronic pelvic pain (CPP). CPP, a complex and often debilitating condition, presents a significant challenge for both patients and healthcare providers as it is often composed of both neuropathic and nociceptive pain. This pilot study will help determine whether CBD reduces pain and improved quality of life is association with CPP.
URI: http://hdl.handle.net/11434/2375
Type: Conference Poster
Affiliated Organisations: Department of Obstetrics, and Gynaecology and Newborn Health, The University of Melbourne and Gynaecology Research Centre, The Royal Women's Hospital, Victoria, Australia
National Institute of Integrative Medicine, Victoria, Australia
Type of Clinical Study or Trial: Pilot Study
Appears in Collections:Research Week

Files in This Item:
File Description SizeFormat  
Endometriosis_Cannabidiol Oil eValuation_DSamaranayake.jpg1.18 MBJPEGThumbnail
View/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.